+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Addiction Disorders Drugs Market Research Reports

Disulfiram (CAS 97-77-8) Global Market Research Report 2024 - Product Thumbnail Image

Disulfiram (CAS 97-77-8) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Methadone (CAS 76-99-3) Global Market Research Report 2024 - Product Thumbnail Image

Methadone (CAS 76-99-3) Global Market Research Report 2024

  • Report
  • November 2024
  • 50 Pages
  • Global
From
From
Europe, MEA Substance Abuse Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Thumbnail Image

Europe, MEA Substance Abuse Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • February 2024
  • 73 Pages
  • Middle East, Africa, Europe Middle East, Africa, Europe
From
From
From
From
Non-opioid Pain Treatment: Global Markets to 2024 - Product Thumbnail Image

Non-opioid Pain Treatment: Global Markets to 2024

  • Report
  • December 2019
  • 165 Pages
  • Global
From
Opioid Drugs: Global Markets to 2023 - Product Thumbnail Image

Opioid Drugs: Global Markets to 2023

  • Report
  • November 2018
  • 147 Pages
  • Global
From
Opioid Use Disorder Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Opioid Use Disorder Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Loading Indicator

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive. The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more